← Evidence map

ReviewCancer immunology, immunotherapy : CII2004

CD44v6: a target for antibody-based cancer therapy.

Karl-Heinz Heider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

95 papers cite itlatest 60 shown

2004
…
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 14762695